Clinical Trial Update: A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

DiObex sponsored a Phase 1/2a trial of the 2S,4R enantiomer of ketoconazole in Type 2 diabetes mellitus. The study has completed its Phase 1 and Phase 2a portio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• 2S,4R enantiomer of ketoconazole (ketoconazole)

Snippet

Sponsor: DiObex | Conditions: Type 2 Diabetes | Phase 1, Phase 2 | Status: COMPLETED